Contraindications Contraindications are specific situations when medications should not be used
Administered weekly at 2.4 mg subcutaneously, semaglutide has secured regulatory clearance in the United States, Europe, the United Kingdom, and Canada for weight management in adults grappling with overweight (BMI 27 kg m2 alongside at least one obesity-related comorbidity) or obesity (BMI 30 kg m2), backed by findings from the Semaglutide Treatment Effect in People with Obesity (STEP) clinical trial program
While using Semaglutide GLP-1 , some people may experience mild side effects, such as nausea or stomach discomfort, particularly when starting the treatment
4.9 (19) 4.7 (25) 4.8 (6) 4.8 (10) 4.8 (5) 5.0 (6) 5.0 (3) 5.0 (16) 5.0 (1) 4.2 (5) Otros productos similares
Your safety and well-being are always our top priorities
So, when you eat anything, the tablet (which works similarly to the GLP-1 hormone) increases insulin production, which further helps to store energy in your muscles and suppress appetite